Self-sustenance is a concept that is gaining traction globally. It involves the ability to meet one’s own needs without relying on external resources. We a pharmaceutical company based in Gujarat, India produces a range of pharmaceutical products, including active pharmaceutical ingredients (APIs), generic drugs, and nutraceuticals. One of the key raw materials used in the production of APIs is para-aminophenol (PAP), which is used to produce paracetamol. For more information visit: https://www.farmson.com/blogs/self-sustenance-a-motto-at-farmson/
Farmson was established in the year 1971 for manufacturing of Paracetamol through phenol route. In the year 2000, we switched over to the PNCB route to manufacture Paracetamol. Currently, we are the GLOBAL LEADER in API Paracetamol production.
Sunday, 28 May 2023
Self-sustenance a motto at Farmson
Self-sustenance is a concept that is gaining traction globally. It involves the ability to meet one’s own needs without relying on external resources. We a pharmaceutical company based in Gujarat, India produces a range of pharmaceutical products, including active pharmaceutical ingredients (APIs), generic drugs, and nutraceuticals. One of the key raw materials used in the production of APIs is para-aminophenol (PAP), which is used to produce paracetamol. For more information visit: https://www.farmson.com/blogs/self-sustenance-a-motto-at-farmson/
Subscribe to:
Post Comments (Atom)
Why India is Becoming a Global Hub for Paracetamol API and Caffeine API Manufacturing
India has emerged as one of the world’s most important pharmaceutical manufacturing hubs, particularly in the production of Active Pharmac...
-
Farmson Basic Drugs is expanding beyond paracetamol with a growing portfolio of high-demand APIs across respiratory, cardiovascular, urology...
-
Farmson Basic Drugs leads in Paracetamol DC Granules manufacturing with an EU GMP-certified facility, 3600 MTPA capacity, and advanced GLATT...
-
Farmson Basic Drugs, a leader in API manufacturing, expands its innovation with a world-class synthetic caffeine facility designed for pharm...
No comments:
Post a Comment